Ipratropium Bromide
NDC 0487-9801, Ipratropium Bromide, solution, from Nephron Pharmaceuticals Corporation.
- Product NDC
- 0487-9801
- Status
- Listed
- Labeler
- Nephron Pharmaceuticals Corporation
- Dosage form
- SOLUTION
- Route
- RESPIRATORY (INHALATION)
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075562
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0487-9801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IPRATROPIUM BROMIDE.5 mg/2.5mL
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0487-9801-01 | 00487980101 | 30 POUCH in 1 CARTON (0487-9801-01) / 1 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE |
| 0487-9801-02 | 00487980102 | 30 BAG in 1 BOX (0487-9801-02) / 1 POUCH in 1 BAG / 1 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE |
| 0487-9801-25 | 00487980125 | 1 POUCH in 1 CARTON (0487-9801-25) / 25 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE |
| 0487-9801-30 | 00487980130 | 1 POUCH in 1 CARTON (0487-9801-30) / 30 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE |
| 0487-9801-60 | 00487980160 | 2 POUCH in 1 CARTON (0487-9801-60) / 30 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/db8095db-d1fd-4099-9fb1-d1ad4e284976Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0487-9801NADAC price for package 00487980101
GET /v1/drugs/nadac/00487980101NADAC price for package 00487980125
GET /v1/drugs/nadac/00487980125NADAC price for package 00487980130
GET /v1/drugs/nadac/00487980130NADAC price for package 00487980160
GET /v1/drugs/nadac/00487980160
Use it
Look up 0487-9801 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0487-9801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0487-9801. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.